Xiao Li

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial

Xiaofeng Chen, Xiaofeng Wu, Hao Wu et al. · Journal for ImmunoTherapy of Cancer · 2020 · 156 citations · Full text

Immunology, Pathology, Metronomic Chemotherapy +17

HuR Is Required for IL-17–Induced Act1-Mediated CXCL1 and CXCL5 mRNA Stabilization

Tomasz Herjan, Peng Yao, Qian Wen et al. · The Journal of Immunology · 2013 · 93 citations · Full text

lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma

Xiao Li, Qi Zhao, Jianni Qi et al. · International Journal of Oncology · 2018 · 73 citations · Full text

Metabolic Remodeling, Tumor Biology, Oxidative Stress +24

Genomic landscape of CD34 ⁺ hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers

Lan Xu, Zhaohui Gu, Yang Li et al. · Proceedings of the National Academy of Sciences · 2014 · 57 citations · Full text

Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs

Peng Zhan, Xiao Li, Zhenyu Li et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 54 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +10